公司资料

Avadel 股价、新闻与催化剂

股票代码:
AVDL
交易所:
NASDAQ
行业:
Biopharma
所在地:
Ireland

股价为何变动

Current closing-price context is not available for AVDL.

公司概览

业务概览

Avadel Pharmaceuticals is a specialty pharmaceutical company focused on sleep medicine, especially narcolepsy-related treatment. Its business is built around a commercial product with ongoing launch and market-expansion opportunities.

所在地与行业分类

Avadel is headquartered in Ireland and listed on NASDAQ. It sits in specialty pharma and sleep medicine.

商业模式特征

The company depends on product adoption, access, and the ability to grow a focused commercial franchise. Investors watch revenue, payer coverage, and label or market expansion.

生物医药行业定位

Avadel occupies a specialty-sleep niche within pharma. It is more commercial than development-stage biotech, but the stock still responds to launch execution and market access.

未来催化剂

  • Avadel’s catalysts are LUMRYZ commercialization and any label or market-expansion step that strengthens the sleep-franchise story. The company’s value is tied to whether the launch keeps scaling.

近期新闻

    相似股票

    商业成熟度、治疗领域或催化剂模式相近的同行公司。